Search Results - "Jantús, E."

Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions by Mayo-de-las-Casas, C., Jordana-Ariza, N., Garzón-Ibañez, M., Balada-Bel, A., Bertrán-Alamillo, J., Viteri-Ramírez, S., Reguart, N., Muñoz-Quintana, M.A., Lianes-Barragan, P., Camps, C., Jantús, E., Remon-Massip, J., Calabuig, S., Aguiar, D., Gil, M.L., Viñolas, N., Santos-Rodríguez, A.K., Majem, M., García-Peláez, B., Villatoro, S., Pérez-Rosado, A., Monasterio, J.C., Ovalle, E., Catalán, M.J., Campos, R., Morales-Espinosa, D., Martínez-Bueno, A., González-Cao, M., González, X., Moya-Horno, I., Sosa, A.E., Karachaliou, N., Rosell, R., Molina-Vila, M.A.

“…In a significant percentage of advanced non-small-cell lung cancer (NSCLC) patients, tumor tissue is unavailable or insufficient for genetic analyses. We…”
Get full text

Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups by MacIntyre, D A, Jiménez, B, Lewintre, E Jantus, Martín, C Reinoso, Schäfer, H, Ballesteros, C García, Mayans, J Ramón, Spraul, M, García-Conde, J, Pineda-Lucena, A

“…Chronic lymphocytic leukaemia (CLL) is a heterogeneous disease exhibiting variable clinical course and survival rates. Mutational status of the immunoglobulin…”
Get full text

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project by Kerr, K.M., Dafni, U., Schulze, K., Thunnissen, E., Bubendorf, L., Hager, H., Finn, S., Biernat, W., Vliegen, L., Losa, J.H., Marchetti, A., Cheney, R., Warth, A., Speel, E.-J., Blackhall, F., Monkhorst, K., Jantus Lewintre, E., Tischler, V., Clark, C., Bertran-Alamillo, J., Meldgaard, P., Gately, K., Wrona, A., Vandenberghe, P., Felip, E., De Luca, G., Savic, S., Muley, T., Smit, E.F., Dingemans, A.-M.C., Priest, L., Baas, P., Camps, C., Weder, W., Polydoropoulou, V., Geiger, T.R., Kammler, R., Sumiyoshi, T., Molina, M.A., Shames, D.S., Stahel, R.A., Peters, S.

“…Reported prevalence of driver gene mutations in non-small-cell lung cancer (NSCLC) is highly variable and clinical correlations are emerging. Using NSCLC…”
Get full text

Clinical impact of using a deep genomic profile in carcinoma of unknown origin by Fernandez Díaz, A., Iranzo, V., Calabuig Fariñas, S., Jantus, E., Cunquero Tomas, A.J., Avila Andrade, C., Sauvage, S., Beniuga, G., Camps, C.J.

Get full text

RING observational trial to compare T790M mutation testing in blood by different methodologies by Garcia-Pelaez, B., Jantus, E., Romero, A., Molina, M.-A., Blasco Cordellat, A., Perez-Barrios, C., Rosell, R., Camps, C., Provencio Pulla, M.

Get full text

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma by Ajona, D, Pajares, MJ, Chiara, MD, Rodrigo, JP, Jantus-Lewintre, E, Camps, C, Suarez, C, Bagán, JV, Montuenga, LM, Pio, R

“…Objective Complement C4d‐containing fragments have been proposed as diagnostic markers for lung cancer. The purpose of this study was to evaluate the presence…”
Get full text

Serum metabolome analysis by H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups by MACINTYRE, D. A, JIMENEZ, B, JANTUS LEWINTRE, E, REINOSO MARTIN, C, SCHÄFER, H, GARCIA BALLESTEROS, C, MAYANS, J. Ramón, SPRAUL, M, GARCIA-CONDE, J, PINEDA-LUCENA, A

Get full text

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping by Zugazagoitia, J., Ramos, I., Trigo, J.M., Palka, M., Gómez-Rueda, A., Jantus-Lewintre, E., Camps, C., Isla, D., Iranzo, P., Ponce-Aix, S., García-Campelo, R., Provencio, M., Franco, F., Bernabé, R., Juan-Vidal, O., Felip, E., de Castro, J., Sanchez-Torres, J.M., Faul, I., Lanman, R.B., Garrido, P., Paz-Ares, L.

“…Approximately 30% of tumor biopsies from patients with advanced-stage lung adenocarcinomas yield insufficient tissue for successful molecular subtyping. We…”
Get full text

Lung tumorspheres as a drug screening platform against cancer stem cells by Herreros Pomares, A., Amado, H., Calabuig Fariñas, S., Escorihuela, E., Murga, J., Torres, S., Durendez-Saez, E., Zhang, F., Blasco, A., Navarro, A., Sampedro, C., Jantus-Lewintre, E., Camps, C.

Get full text

Applicability of ctDNA at diagnosis and during the monitoring of EGFR-mutated patients by Calabuig Fariñas, S., Blasco, A., Durendez-Saez, E., Fernández, A., Mosqueda, M., Escorihuela, E., Herreros Pomares, A., Aparisi, F., Garde, J., Shahin, M., Jantus-Lewintre, E., Camps, C.

Get full text

Interactions of cancer stem cell and immune microenvironment in non-small cell lung cancer (NSCLC) by Zhang, F., Dong, N., Torres, S., Calabuig Fariñas, S., Sirera Perez, R., Mosqueda, M., Escorihuela, E., Jantus-Lewintre, E., Camps, C.

Get full text

Exosomes in NSCLC: Analysis of its cargo as a source of biomarkers by Durendez-Saez, E., Calabuig Fariñas, S., Suarez, C., Mosqueda, M., Gallach, S., Escorihuela, E., Moreno, A., Dong, N., Herreros Pomares, A., de la Cueva, E., Martinez-Romero, A., Serna, E., Paramio, J.M., Jantus-Lewintre, E., Camps, C.

Get full text

An expression signature characterizes cancer stem cells from lung adenocarcinoma patients by Herreros-Pomares, A., Calabuig Fariñas, S., de Maya, J.D., Escorihuela, E., Durendez-Saez, E., Blasco Cordellat, A., Navarro, A., García-Del-Olmo, E., Lucas, R., Farràs, R., Jantus-Lewintre, E., Camps, C.

Get full text

CD5 and CD6: Evaluation of their role as prognostic biomarkers in resectable non-small cell lung cancer by Moreno, A., Calabuig Fariñas, S., Gallach Garcia, S., Fernando, A., Simoes, I., Carreras, E., Consuegra-Fernández, M., Blasco Cordellat, A., Cunquero Tomas, A.J., Martorell, M., Camps, C., Lozano, F., Sirera Perez, R., Jantus-Lewintre, E.

Get full text

High-throughput screening of new drugs targeting lung CSCs by Amado Labrador, H.A., Jantus-Lewintre, E., Calabuig Fariñas, S., Aguilar-Gallardo, C., Murga, J., Munera-Maravilla, E., Durendez-Saez, E., Mosqueda, M., Escorihuela, E., Zhang, F., Masiá, E., Dong, N., Guijarro, R., Camps, C.

Get full text

Soluble immune biomarkers to anti-PD1 treatment in non-small cell lung cancer (NSCLC) by Garde-Noguera, J., Jantus-Lewintre, E., Honrubia Peris, B., Gallach Garcia, S., Zhang, F., García Sánchez, J., Calabuig Fariñas, S., Blasco Cordellat, A., Piera Molons, N., Vidal-Martinez, J., Murado-Pardo, J., Condori Farfan, L.D., Gisbert-Criado, R., Escorihuela, E., Camps, C.

Get full text

Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis by Gil-Raga, M., Jantus-Lewintre, E., Gallach, S., Giner-Bosch, V., Frangi-Caregnato, A., Safont-Aguilera, M. J., Garde-Noguera, J., Zorraquino-Pina, E., García-Martínez, M., Camps-Herrero, C.

“…Purpose After surgical resection, an ample prognosis variability among stages is observed. Multiple prognostic factors are individually studied and some CRC…”
Get full text

Carcinoma of unknown origin: Deep genomic profile helps to achieve an accurate diagnosis by Fernandez Díaz, A.B., Iranzo Gonzalez-Cruz, V., Cunquero Tomas, A.J., Avila Andrade, C., Jantus-Lewintre, E., Calabuig Fariñas, S., Ales, J.E., Valero, M., D'Errico, G., Pazo Cid, R.A., Gallego Martínez, A., Viana, A., Ponce Aix, S., Pérez-Fidalgo, J.A., Terradez, A., Rodrigo, A., Alvarez, L., Beniuga, G., Martorell, M., Camps, C.

Get full text

122 Analysis of immune-response markers in resectable NSCLC by Usó, M, Jantus-Lewintre, E, Sirera, R, Calabuig-Fariñas, S, Gallach, S, Escorihuela, E, Blasco, A, Guijarro, R, Camps, C

Get full text

133 Analysis of immune microenvironment in resectable NSCLC: Prognostic value of regulatory and conventional T cell markers proportion by Uso, M, Sirera, R, Calabuig-Fariñas, S, Blasco, A, Pastor, E, Guijarro, R, Jantus-Lewintre, E, Forteza, J, Camps, C

Get full text